Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRXGet Free Report) in a research report issued on Monday. The brokerage set a “hold” rating on the software maker’s stock.

A number of other research firms also recently weighed in on MDRX. Barclays began coverage on shares of Veradigm in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 price target on the stock. Royal Bank of Canada decreased their price objective on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a report on Friday, January 19th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $11.25.

View Our Latest Analysis on Veradigm

Veradigm Trading Down 0.8 %

NASDAQ MDRX opened at $7.45 on Monday. Veradigm has a twelve month low of $5.01 and a twelve month high of $14.09. The firm’s 50 day moving average price is $7.85 and its two-hundred day moving average price is $10.19.

Institutional Investors Weigh In On Veradigm

A number of hedge funds have recently bought and sold shares of MDRX. Bank of New York Mellon Corp boosted its holdings in Veradigm by 3.1% during the first quarter. Bank of New York Mellon Corp now owns 1,323,414 shares of the software maker’s stock valued at $29,803,000 after acquiring an additional 39,210 shares during the period. Citigroup Inc. boosted its holdings in Veradigm by 1.8% during the first quarter. Citigroup Inc. now owns 118,927 shares of the software maker’s stock valued at $2,678,000 after acquiring an additional 2,157 shares during the period. Natixis Advisors L.P. boosted its holdings in Veradigm by 23.8% during the first quarter. Natixis Advisors L.P. now owns 86,478 shares of the software maker’s stock valued at $1,948,000 after acquiring an additional 16,642 shares during the period. Bank of Montreal Can boosted its holdings in Veradigm by 3.6% during the first quarter. Bank of Montreal Can now owns 34,210 shares of the software maker’s stock valued at $768,000 after acquiring an additional 1,198 shares during the period. Finally, MetLife Investment Management LLC boosted its holdings in Veradigm by 57.0% during the first quarter. MetLife Investment Management LLC now owns 68,294 shares of the software maker’s stock valued at $1,538,000 after acquiring an additional 24,794 shares during the period.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.